ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Paul E. Clancy
Marvin M. Kirsh
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clancy, P. E.
Right arrow Articles by Kirsh, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clancy, P. E.
Right arrow Articles by Kirsh, M. M.

Ann Thorac Surg 1981;31:558-563
© 1981 The Society of Thoracic Surgeons


Articles

Substrate Cardioplegia during Hypothermic Arrest in the Alloxan Diabetic Dog

Paul E. Clancy, M.D., A. David Slater, M.D., David Brandt, A.B., Marvin M. Kirsh, M.D.*

University of Michigan Medical Center, Section of Thoracic Surgery, Ann Arbor, MI

Accepted for publication October 27, 1980.

* Address reprint requests to Dr. Kirsh, Professor of Surgery, University of Michigan Medical Center, Section of Thoracic Surgery, C7079, Box 32, Ann Arbor, MI 48109

In an experimental study, 26 mongrel dogs were treated with alloxan (50 mg per kilogram) to induce fasting hyperglycemia and diabetes. The animals were randomly subdivided into two groups, one of which received 100 mg of propranolol in divided doses for two weeks. The animals underwent sternotomy and were placed on total cardiopulmonary bypass. After aortic cross-clamping, each animal received 10 ml per kilogram of cardioplegic solution. Two different solutions were used, a standard hyperkalemic solution and a high-energy glucose-insulin-potassium (GIK) substrate. Baseline studies were made on the four groups of diabetic animals.

Animals given potassium cardioplegia but no propranolol showed statistically significant decreases in cardiac index, heart rate, mean arterial pressure, and minute left ventricular stroke work index after bypass. In contrast, animals given GIK cardioplegia but no propranolol showed no changes in any of these measurements. Animals administered propranolol and potassium cardioplegia experienced decrease in mean arterial pressure from 77.5 ± 14.1 mm Hg before bypass to 57.5 ± 17.8 mm Hg after bypass. A similar reduction occurred in animals given propranolol and GIK cardioplegia. However, in this group, the cardiac index increased from 1.78 ± 0.38 L/min/m2 before bypass to 2.96 ± 0.73 L/min/m2 after bypass (p < .006). Similarly, the minute left ventricular stroke work index increased after bypass in these animals. This study demonstrates the protective effect against myocardial ischemia of the addition of substrate to the cardioplegic solution in diabetic animals subjected to aortic cross-clamping during cardiopulmonary bypass, one group receiving propranolol and one group not receiving it.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
V. R. Conti and R. L. Kao
Metabolic and Functional Effects of Carbohydrate Substrate with Single-Dose and Multiple-Dose Potassium Cardioplegia
Ann. Thorac. Surg., September 1, 1983; 36(3): 320 - 327.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1981 by The Society of Thoracic Surgeons.